Business · 28/10/2010Updated: 10/17/2026 · 1 min read
FDA's Cellular, Tissue and Gene Therapies Advisory Committee to Meet on Upcoming Therapies
Summary
The US Food and Drug Administration's Cellular, Tissue and Gene Therapies Advisory Committee will convene to discuss and review emerging cellular, tissue, and gene therapies, including recent developments and proposals for future treatments.
Original source language: Federal Register — Health and Human ServicesOpen original release →